Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Chronic Intermittent Sucrose Consumption Facilitates the Ability to Discriminate Opioid Receptor Blockade with Naltrexone in Rats. Nutrients 2022 Feb 22;14(5)

Date

03/11/2022

Pubmed ID

35267900

Pubmed Central ID

PMC8912831

DOI

10.3390/nu14050926

Scopus ID

2-s2.0-85125184551 (requires institutional sign-in at Scopus site)   3 Citations

Abstract

The opioid antagonist naltrexone (NTX) decreases intake of preferred diets in rats at very low doses relative to doses needed to decrease intake of "bland" laboratory chow. In the absence of an opioid agonist, NTX is not discriminable using operant techniques. In the current study, we found that rats given intermittent access to a 25% sucrose solution learned to discriminate between various naltrexone doses and saline. None of the rats given only water learned to discriminate between naltrexone and saline. When access to the sucrose solution was discontinued for 14 days, the rats lost the ability to discriminate between NTX and saline. We also studied the changes of c-Fos IR in selected brain regions in rats treated with saline versus NTX that were drinking water or 25% sucrose. An injection of NTX or saline resulted in a significant drug, diet, and interaction effect in various brain regions associated with feeding behavior, particularly the amygdala, accumbens, and hypothalamic sites. Thus, we found that ingestion of a sucrose solution results in the ability of rats to reliably discriminate naltrexone administration. In addition, sucrose and naltrexone altered c-Fos IR in an interactive fashion in brain regions known to be involved in ingestion behavior.

Author List

Jewett DC, Liyanagamage DSNK, Avond MAV, Anderson MAB, Twaroski KA, Marek MA, James KF, Pal T, Klockars A, Olszewski PK, Levine AS

Author

Mark A. Vanden Avond Research Scientist I in the Physiology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Animals
Feeding Behavior
Naltrexone
Narcotic Antagonists
Rats
Receptors, Opioid
Sucrose